AAPL   329.75 (+2.31%)
MSFT   185.69 (+1.51%)
FB   230.71 (+1.95%)
GOOGL   1,439.28 (+1.77%)
NVDA   354.60 (+1.05%)
BABA   219.54 (+0.69%)
GE   8.23 (+6.33%)
TSLA   873.78 (+1.09%)
GILD   77.24 (-0.39%)
DIS   126.70 (+2.43%)
NFLX   414.05 (-0.07%)
BAC   28.43 (+6.12%)
BA   215.30 (+16.82%)
AAPL   329.75 (+2.31%)
MSFT   185.69 (+1.51%)
FB   230.71 (+1.95%)
GOOGL   1,439.28 (+1.77%)
NVDA   354.60 (+1.05%)
BABA   219.54 (+0.69%)
GE   8.23 (+6.33%)
TSLA   873.78 (+1.09%)
GILD   77.24 (-0.39%)
DIS   126.70 (+2.43%)
NFLX   414.05 (-0.07%)
BAC   28.43 (+6.12%)
BA   215.30 (+16.82%)
AAPL   329.75 (+2.31%)
MSFT   185.69 (+1.51%)
FB   230.71 (+1.95%)
GOOGL   1,439.28 (+1.77%)
NVDA   354.60 (+1.05%)
BABA   219.54 (+0.69%)
GE   8.23 (+6.33%)
TSLA   873.78 (+1.09%)
GILD   77.24 (-0.39%)
DIS   126.70 (+2.43%)
NFLX   414.05 (-0.07%)
BAC   28.43 (+6.12%)
BA   215.30 (+16.82%)
AAPL   329.75 (+2.31%)
MSFT   185.69 (+1.51%)
FB   230.71 (+1.95%)
GOOGL   1,439.28 (+1.77%)
NVDA   354.60 (+1.05%)
BABA   219.54 (+0.69%)
GE   8.23 (+6.33%)
TSLA   873.78 (+1.09%)
GILD   77.24 (-0.39%)
DIS   126.70 (+2.43%)
NFLX   414.05 (-0.07%)
BAC   28.43 (+6.12%)
BA   215.30 (+16.82%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Progenics PharmaceuticalsFlexion TherapeuticsOrganiGramBioDelivery Sciences InternationalSatsuma Pharmaceuticals
SymbolNASDAQ:PGNXNASDAQ:FLXNNASDAQ:OGINASDAQ:BDSINASDAQ:STSA
Price Information
Current Price$4.63$11.96$1.76$4.85$26.95
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.42.41.61.91.5
Analysis Score3.54.64.33.42.5
Community Score2.63.03.23.12.4
Dividend Score0.00.00.00.00.0
Ownership Score1.04.00.01.02.0
Earnings & Valuation Score0.00.60.61.90.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$12.00$23.33$6.46$8.71$33.00
% Upside from Price Target159.18% upside95.09% upside267.14% upside79.73% upside22.45% upside
Trade Information
Market Cap$397.49 million$463.11 million$307.48 million$482.52 million$458.21 million
Beta1.892.05N/A0.77N/A
Average Volume562,6611,310,5327,241,263866,45841,129
Sales & Book Value
Annual Revenue$34.99 million$72.96 million$61.27 million$111.39 millionN/A
Price / Sales11.466.325.054.35N/A
CashflowN/AN/A$0.10 per share$0.19 per shareN/A
Price / CashN/AN/A17.7225.78N/A
Book Value$0.54 per share($0.53) per share$1.58 per share$0.78 per share$6.64 per share
Price / Book8.57-22.571.116.21N/A
Profitability
Net Income$-68,550,000.00$-149,770,000.00$-7,200,000.00$-15,310,000.00$-28,170,000.00
EPS($0.80)($3.93)$0.06$0.10($4.80)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A29.3311.01N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-180.28%-175.76%-45.14%-5.01%N/A
Return on Equity (ROE)-129.46%-592.50%-5.33%23.61%N/A
Return on Assets (ROA)-53.23%-64.53%-4.00%9.21%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.99%27.76%N/A0.77%0.02%
Current Ratio2.12%5.08%1.87%2.19%15.05%
Quick Ratio2.12%4.52%0.60%1.94%15.05%
Ownership Information
Institutional Ownership Percentage70.96%83.08%11.50%73.64%79.40%
Insider Ownership Percentage4.26%16.01%N/A8.94%45.65%
Miscellaneous
Employees7928861517811
Shares Outstanding86.60 million38.56 million175.70 million99.90 million17.39 million
Next Earnings Date8/14/2020 (Estimated)8/4/2020 (Estimated)7/20/2020 (Estimated)8/13/2020 (Estimated)8/11/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.